A PHASE 2B STUDY OF SELINEXOR IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL). (12th June 2019)

• Record Type: Journal Article
• Authors: Kalakonda, N.; Cavallo, F.; Follows, G.; Goy, A.; Vermaat, J.; Casasnovas, O.; Lavee, O.; Maerevoet, M.; Zijlstra, J.; Bakshi, S.; Bouabdallah, R.; Choquet, S.; Gurion, R.; Hill, B.; Jaeger, U.; Sancho, J.; Schuster, M.; Thieblemont, C.; De la Cruz, F.; Egyed, M.; Mishra, S.; Offner, F.; Vassilakopoulos, T.; Warzocha, K.; Oluyadi, A.; McCarthy, D.; Ma, X.; Corona, K.; Shah, J.; Van Den Neste, E.; Canales, M.;
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 62
• Page End: 64
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.31_2629
• Languages: English
• ISSNs: 0278-0232